PlainRecalls
FDA Drug Moderate Class II Completed

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

Reported: January 8, 2025 Initiated: December 20, 2024 #D-0167-2025

Product Description

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Details

Units Affected
480 1000-count bottles
Distribution
One US distributor in Ohio.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 480 1000-count bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 8, 2025. Severity: Moderate. Recall number: D-0167-2025.